Peritoneal Dialysis International Journal

Just starting for Africa Chapter Webinar! Join here bit.ly/41mU2OY

Starting now!

Clinical Pearl: A review of 67 M. abscessus PD infections showed 6 historical cases treated with clofazimine achieved cure. This is the FIRST reported success for a macrolide-resistant strain! Clofazimine is a viable oral combo-therapy option. 5/5

The Results: After 4 weeks of imipenem-cilastatin, amikacin, azithromycin, and clofazimine, followed by 4 months of continuation therapy, the patient achieved sustained clinical cure! He remains recurrence-free at 14 months follow-up. 4/5

A new Case Report in #PDI explores how a clofazimine-inclusive combination therapy successfully treated a stubborn, macrolide-resistant Mycobacterium abscessus PD infection! 🧵 1/5 journals.sagepub.com/doi/10.1177/08… #peritonealdialysis #ISPD

6/6 📝 Takeaway: Don't wait for the cocoon. In long-term PD patients, monitor ascites production rates during pauses. It could be the key to early EPS intervention. Read the full paper by Hsieh et al. in @PDI_Journal

5/6 ✅ Outcome: Ascites volume decreased over time, and the patient's weight and appetite recovered. This highlights that "rapid accumulation" can be a vital early warning sign in high-risk patients.

1/6 🧵 Diagnosing Encapsulating Peritoneal Sclerosis (EPS) early is notoriously difficult. A new case in #PDI suggests a subtle clinical sign may precede definitive radiological evidence. #PeritonealDialysis #PD #Nephrology 🔗 doi.org/10.1177/089686…

Excited to welcome Dr. Jeffrey Perl @PD_Perls (@UofT , @UnityHealthTO) on Tues 1/20/26 for a special lecture “#PeritonealDialysis: Where Are We Going? Where Have We Been?” Join us 12–1 p.m. in Chromalloy Conference Rm. Lunch provided. nephrology.wustl.edu/visiting-profe…

Is it safe to start #PeritonealDialysis early (<2 weeks) after placement? A review from @UTSW_Surgery @UTSWSurgeryLife suggest early initiation of PD may be a viable option, especially in resource constrained settings! @CPark_MD @JHarvMD20 Link: doi.org/10.1177/000313…

🚨 New from our group @PDI_Journal @HospitalJuarezM 💧🌍 Peritoneal dialysis (PD) generates large volumes of effluent that are usually discarded. Could this resource be reused? 👉 Evidence supporting #GreenNephrology DOI: 10.1177/08968608261415964 #PeritonealDialysis We biochemically and microbiologically characterized peritoneal dialysis effluent (PDE) and compared it with treated wastewater from urban and industrial plants. #Sustainability ♻️ With advanced treatments (RO, NF, UF), PDE could be reused for non-potable agricultural or industrial purposes, opening new paths for sustainable dialysis care. #WaterReuse journals.sagepub.com/doi/10.1177/08…

📢 #ISPD Open Call for #Research Projects on #PeritonealDialysis Submit your Proposals for project endorsement and support! Book an informal discussion with the International Studies Committee ahead of submission. 🚨Final Deadline: Feb 15🚨 🔗 Details: ispd.org/research-proje…

So excited that the @ISPDCongress Abstract deadline has been extended to 18 Jan. Don’t miss out. @ISPD1 @IPNA_PedNeph @international society of nephrology Saving Young Lives. ispd2026.org.za

#PDExchange Podcast returns with hosts @dr_nikhilshah and @PD_Perls to discuss the @ISPD1 position paper on Teaching PD published in @PDI_Journal Paper - bit.ly/4rpVKKY Podcast Links - Spotify - bit.ly/3UbmFLj Apple - bit.ly/3WSA4d8

🧬 Join the #ISPD NAC JournalClub discussion!
Topic: PD outcomes in myeloma-related kidney disease — data from the French PD Registry 🇫🇷 🌍 Attend in your time zone – options available!
🔗 ispd.org/NAC/jcs/
@PDI_Journal @ISPD1